Blog

  1. ETF128 Successfully Registered with Italian Health Ministry

    The company is gratified to announce successful registration of the ETF128 with the Italian Ministry of Health, clearing the way for entry into the Italian market. This is an important milestone as it is represents the company’s first expansion into the EU. The company plans to sell its products through an authorized representative per Ministry […]

  2. ETF Clinical Cases: Peripheral Neuropathy Secondary to Untreated Hypothyroidism

    Although more closely associated with carpal tunnel syndrome, hypothyroidism is a recognized cause of peripheral neuropathy. While the mechanism of neuropathy in untreated hypothyroidism is unclear, researchers have theorized that it may be attributed to the deposition of mucopolysaccharides or to the accumulation of soft tissue edema in proximity to peripheral nerves. Regardless of the […]

  3. Evidence-based Links between Sympathetic Vascular Dysfunction and C-fiber Neuropathy

    Researchers have long suspected a connection between sympathetic vascular dysfunction and small fiber neuropathy in diabetic patients. This is of special significance regarding the plantar skin of the foot where many diabetic complications arise. Several studies have found reduced vasomotor control to this skin in diabetics with diabetic peripheral neuropathy (DPN). Although the underlying mechanisms […]

  4. Dr. O’Brien Lectures at Midwest Podiatry Conference

    Company CEO, Todd O’Brien, recently delivered a lecture on diabetic peripheral neuropathy to the attendees at the Midwest Podiatry Conference in Chicago. “It was an honor to be asked to lecture at the Midwest.” Dr. O’Brien noted. ” Not only is this one of the best attended and most prestigious meetings in the US, it […]

  5. O’Brien Medical Awarded Grant for ETF Feature Enhancement

    The company is pleased to announce recent seed grant approval from the Maine Technology Institute (MTI). The award will be used to develop a proof-of-concept prototype designed to extend the feature set of the company’s core product, the ETF.  Much of the work will be done in collaboration with the University of Maine’s Department of […]